Pathophysiological-based treatments of complications of cirrhosis

被引:7
作者
Moller, Soren [1 ]
Kimer, Nina [2 ,3 ]
Barlose, Mads [1 ]
Bendtsen, Flemming [2 ]
机构
[1] Copenhagen Univ Hosp, Dept Clin Physiol & Nucl Med, Ctr Funct & Diagnost Imaging & Res, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark
[2] Univ Copenhagen, Gastro Unit, Div Med, Hvidovre Hosp,Fac Hlth Sci, Copenhagen, Denmark
[3] Univ Copenhagen, Novo Nordisk Fdn, Bridge Translat Excellence Programme, Ctr Basic Metab Res, Copenhagen, Denmark
关键词
Portal hypertension; ascites; oesophageal varices; hyperdynamic circulation; hepatorenal syndrome; hepatopulmonary syndrome; NITRIC-OXIDE SYNTHASE; PORTAL-HYPERTENSION RELATION; HEPATIC STELLATE CELLS; ARGININE METHYL-ESTER; CHRONIC LIVER-FAILURE; NECROSIS-FACTOR-ALPHA; PORTOPULMONARY HYPERTENSION; HEPATOPULMONARY SYNDROME; BETA-BLOCKERS; HYPERDYNAMIC CIRCULATION;
D O I
10.1080/00365521.2020.1744709
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Detailed knowledge and understanding of the pathophysiological mechanisms and changes in hepatic and splanchnic function leading to the development of haemodynamic changes and portal hypertension in patients with cirrhosis are essential since it guides the search for targets to ameliorate liver-related abnormalities. Recent research has focused on the gut-liver axis, changes in intestinal permeability, translocation of bacterial products, and inflammation as important drivers of haemodynamic alterations and thereby targets for treatment. Additionally, treatment strategies should focus on microbiotic modulation, antiangiogenics, anti-inflammatory strategies, and modulation of bile acid metabolism. This paper aims to review contemporary pathophysiological-based treatment principles of the major complications of cirrhosis and portal hypertension and future targets for treatment.
引用
收藏
页码:383 / 394
页数:12
相关论文
共 149 条
[1]   Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state [J].
Abraldes, JG ;
Iwakiri, Y ;
Loureiro-Silva, M ;
Haq, O ;
Sessa, WC ;
Groszmann, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (05) :G980-G987
[2]   Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis [J].
Abraldes, Juan G. ;
Villanueva, Candid ;
Aracil, Carles ;
Turnes, Juan ;
Hernandez-Guerra, Manuel ;
Genesca, Joan ;
Rodriguez, Manuel ;
Castellote, Jose ;
Carlos Garcia-Pagan, Juan ;
Torres, Ferran ;
Luis Calleja, Jose ;
Albillos, Agustin ;
Bosch, Jaime .
GASTROENTEROLOGY, 2016, 150 (05) :1160-+
[3]   Treatment Barriers in Portopulmonary Hypertension [J].
AbuHalimeh, Batool ;
Krowka, Michael J. ;
Tonelli, Adriano R. .
HEPATOLOGY, 2019, 69 (01) :431-443
[4]   End-points for drug treatment in NASH [J].
Adams, Leon A. .
HEPATOLOGY INTERNATIONAL, 2019, 13 (03) :253-258
[5]   Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension [J].
Afzelius, Pia ;
Bazeghi, Nassim ;
Bie, Peter ;
Bendtsen, Flemming ;
Vestbo, Jorgen ;
Moller, Soren .
LIVER INTERNATIONAL, 2011, 31 (09) :1381-1387
[6]   Time Trends in the Health Care Burden and Mortality of Acute on Chronic Liver Failure in the United States [J].
Allen, Alina M. ;
Kim, W. Ray ;
Moriarty, James P. ;
Shah, Nilay D. ;
Larson, Joseph J. ;
Kamath, Patrick S. .
HEPATOLOGY, 2016, 64 (06) :2165-2172
[7]   Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome [J].
Ames, Paul R. J. ;
Guardascione, Marianna ;
Batuca, Joana R. ;
Arcaro, Alessia ;
Gentile, Fabrizio ;
Amitrano, Lucio .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (01) :73-77
[8]   News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document [J].
Angeli, Paolo ;
Garcia-Tsao, Guadalupe ;
Nadim, Mitra K. ;
Parikh, Chirag R. .
JOURNAL OF HEPATOLOGY, 2019, 71 (04) :811-822
[9]   Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites [J].
Angeli, Paolo ;
Sanyal, Arun ;
Moller, Soren ;
Alessandria, Carlo ;
Gadano, Adrian ;
Kim, Ray ;
Sarin, Shiv K. ;
Bernardi, Mauro .
LIVER INTERNATIONAL, 2013, 33 (01) :16-23
[10]   The role of autonomic dysfunction in cirrhotic patients before and after liver transplantation. Review of the literature [J].
不详 .
LIVER INTERNATIONAL, 2016, 36 (08) :1081-1089